Education
About Us
Working with TipRanks
Follow Us
Emergent Biosolutions (EBS)
NYSE:EBS
EBS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.82 - $15.10
Previous CloseN/A
Volume320.20K
Average Volume (3M)1.43M
Market Cap
$238.54M
Enterprise Value$983.86M
Total Cash (Recent Filing)$116.38M
Total Debt (Recent Filing)$64.96M
Price to Earnings (P/E)―
Beta2.74
Next Earnings
Apr 24, 2025EPS Estimate
0.16Last Dividend Ex-Date
Aug 01, 2016Dividend YieldN/A
Share Statistics
EPS (TTM)-3.72
Shares Outstanding54,337,025
10 Day Avg. Volume1,489,534
30 Day Avg. Volume1,431,789
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.30
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market Cap4.12
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.97
Enterprise Value/Ebitda25.42
Forecast
1Y Price Target
$15.00Price Target Upside241.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Bulls Say, Bears Say
Bulls Say
Share Repurchase ProgramThe announcement of a share repurchase program reflects management's belief that the shares remain undervalued.
Strategic AlliancesRocketvax strategic relationship marks expansion of vaccine pipeline and access to novel technological approaches.
Bears Say
Generic CompetitionRisks include faster-than-anticipated NARCAN franchise erosion due to greater-than-anticipated levels of generic competition.
Revenue PerformanceEmergent BioSolutions reported a moderate miss in top-line revenue, recording $1.04B compared to expectations of ~$1.12B.
---
Ownership Overview
3.68% Insiders
11.17% Mutual Funds
11.15% Other Institutional Investors
54.79% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EBS FAQ
What was Emergent Biosolutions’s price range in the past 12 months?
Emergent Biosolutions lowest stock price was $1.82 and its highest was $15.10 in the past 12 months.
What is Emergent Biosolutions’s market cap?
Emergent Biosolutions’s market cap is $238.54M.
When is Emergent Biosolutions’s upcoming earnings report date?
Emergent Biosolutions’s upcoming earnings report date is Apr 24, 2025 which is in 10 days.
How were Emergent Biosolutions’s earnings last quarter?
Emergent Biosolutions released its earnings results on Mar 03, 2025. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of -$0.503 by $0.553.
Is Emergent Biosolutions overvalued?
According to Wall Street analysts Emergent Biosolutions’s price is currently Undervalued.
Does Emergent Biosolutions pay dividends?
Emergent Biosolutions pays a Notavailable dividend of $1.855 which represents an annual dividend yield of N/A. See more information on Emergent Biosolutions dividends here
What is Emergent Biosolutions’s EPS estimate?
Emergent Biosolutions’s EPS estimate is 0.16.
How many shares outstanding does Emergent Biosolutions have?
Emergent Biosolutions has 54,337,025 shares outstanding.
What happened to Emergent Biosolutions’s price movement after its last earnings report?
Emergent Biosolutions reported an EPS of $0.05 in its last earnings report, beating expectations of -$0.503. Following the earnings report the stock price went down -6.442%.
Which hedge fund is a major shareholder of Emergent Biosolutions?
Currently, no hedge funds are holding shares in EBS
---
Emergent Biosolutions Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.00 (241.69% Upside)
$15.00 (241.69% Upside)
Blogger Sentiment
Bullish
EBS Sentiment 88%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 1.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $261.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.3%
Last 30 Days ▼ 4.9%
Last 30 Days ▼ 4.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
100.45%
12-Months-Change
Fundamentals
Return on Equity
-33.67%
Trailing 12-Months
Asset Growth
-23.87%
Trailing 12-Months
Company Description
Emergent Biosolutions
Emergent BioSolutions Inc. (EBS) is a life sciences company that focuses on providing solutions for public health threats. The company operates in the biotechnology and pharmaceuticals sectors, specializing in the development, manufacturing, and distribution of medical countermeasures against chemical, biological, radiological, nuclear (CBRN) threats, emerging infectious diseases, and opioid overdose. Its core products include vaccines, therapeutics, and devices for biodefense and public health preparedness.
---
EBS Company Deck
---
EBS Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented significant achievements in financial stability and operational efficiency, highlighted by debt reduction and cost savings. However, revenue challenges, including a decline in NARCAN sales and conservative future guidance, indicate ongoing challenges. The sentiment is balanced with notable improvements offset by revenue pressures.Read More>---
EBS Stock 12 Month Forecast
Average Price Target
$15.00
▲(241.69% Upside)
Technical Analysis
Dynavax
―
Lifecore Biomedical
―
SIGA Technologies
―
ANI Pharmaceuticals
―
Aquestive Therapeutics
―
Best Analysts Covering EBS
1 Year
1 Year Success Rate
5/20 ratings generated profit
1 Year Average Return
-10.79%
initiated a buy rating 8 months ago
Copying Brandon Folkes's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -10.79% per trade.
---